https://pharmasyc.com/why-the-next-wave-of-pharma-value-will-be-sourced-not-invented-in-house/2026-03-10T09:00:00+00:00https://pharmasyc.com/reading-a-data-package-the-way-a-strategic-buyer-will/2026-03-04T09:00:00+00:00https://pharmasyc.com/structuring-milestones-that-hold-up-after-the-deal-closes/2026-02-19T09:00:00+00:00https://pharmasyc.com/the-gulf-as-capital-partner-not-just-a-market/2026-02-06T09:00:00+00:00https://pharmasyc.com/newco-or-sell-down-choosing-the-right-path-for-a-carve-out/2026-01-22T09:00:00+00:00https://pharmasyc.com/what-changed-in-cross-border-china-biotech-partnering-this-year/2026-01-09T09:00:00+00:00